Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer

Keyword: Monolayer

Publisher: Nature.com

Published: Aug 11, 2026

Ethics statement The trial was conducted in accordance with the Good Clinical Practice guidelines of the International Council for Harmonization and the principles of the Declaration of Helsinki. Th… [+29468 chars]

Read Full Story ↗